A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

Clinical trial NCT05571943 · COMPLETED

Trial details

NCT number: NCT05571943
Sponsor: Acrotech Biopharma Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2022-09-15
Primary completion: 2024-07-31
Enrollment: 542

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.